Last reviewed · How we verify
Coronary Vasodilator
Coronary Vasodilator is a Small molecule drug developed by Jun Li. It is currently FDA-approved.
At a glance
| Generic name | Coronary Vasodilator |
|---|---|
| Sponsor | Jun Li |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study (NA)
- Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow (PHASE3)
- Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. (PHASE4)
- Effect of iNO in Patients With Submassive and Massive PE (PHASE2)
- Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy (PHASE1, PHASE2)
- N2O for Acute Suicidality and Depression in the ED (PHASE2)
- Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension (NA)
- A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Coronary Vasodilator CI brief — competitive landscape report
- Coronary Vasodilator updates RSS · CI watch RSS
- Jun Li portfolio CI
Frequently asked questions about Coronary Vasodilator
What is Coronary Vasodilator?
Coronary Vasodilator is a Small molecule drug developed by Jun Li.
Who makes Coronary Vasodilator?
Coronary Vasodilator is developed and marketed by Jun Li (see full Jun Li pipeline at /company/jun-li).
What development phase is Coronary Vasodilator in?
Coronary Vasodilator is FDA-approved (marketed).
Related
- Manufacturer: Jun Li — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing